临床肿瘤学杂志

• 论著 • 上一篇    下一篇

非小细胞肺癌组织中miR-449a/b/c的表达及临床意义

贺文财,金丽山,李华   

  1. 810007 西宁 青海省第五人民医院肿瘤科
  • 收稿日期:2017-01-14 修回日期:2017-02-15 出版日期:2017-04-30 发布日期:2017-04-30

Analysis of miR-449a/b/c expressions and their clinical significance in non-small cell lung cancer

HE Wencai,JIN Lishan,LI Hua   

  1. Department of Oncology,the Fifth Peoples Hospital of Qinghai Province, Xining 810007,China
  • Received:2017-01-14 Revised:2017-02-15 Online:2017-04-30 Published:2017-04-30

摘要: 目的 探讨非小细胞肺癌(NSCLC)组织中微小RNA(miRNA)-449a/b/c的表达水平、临床意义及与预后的关系。方法 收集2013年1月至2015年12月收治的82例手术切除的NSCLC组织及69例癌旁组织标本,采用荧光实时定量PCR(QPCR)法检测以上组织中miR-449a/b/c的表达并比较3者在NSCLC组织及癌旁组织中的分布差异,Pearson相关分析NSCLC组织中miR-449a、miR-449b和miR-449c表达的相关性,分析NSCLC组织中miR-449a/b/c表达与临床病理特征(性别、年龄、肿瘤大小、TNM分期、组织学类型和淋巴结转移)的关系,同时根据随访数据比较不同miR-449a/b/c表达患者的预后情况。结果 QPCR结果显示,NSCLC组织中miR-449a、miR-449b和miR-449c的平均表达量依次为0.210±0.028、0.359±0.031和0.133±0.020,均低于癌旁组织,差异有统计学意义(P<0.05);NSCLC组织中miR-449a、miR-449b和miR-449c的表达均呈正相关,相关系数rmiR-449a/b、rmiR-449a/c和rmiR-449b/c分别为0.246、0.390和0.331(P<0.05);NSCLC组织中miR-449a/b/c表达均与TNM分期有关,miR-449a和miR-449c表达与肿瘤大小有关。全组中位总生存期(OS)为12.4个月,其中miR-449a低表达组和高表达组的中位OS分别为11.2个月和13.5个月(P>0.05),miR-449b低表达组和高表达组的中位OS分别为9.6个月和14.2个月(P<0.05),miR-449c低表达组和高表达组的中位OS分别为11.7个月和13.7个月(P>0.05)。结论 miR-449a/b/c在NSCLC组织中表达降低,且均与TNM分期有关,miR-449b表达与预后有关,可能与NSCLC发生、发展有关,对NSCLC诊断及病情评估有一定价值。

Abstract: Objective To investigate the expression and clinical significance of miR-449a/b/c in non-small cell lung cancer(NSCLC)as well as their expressions with prognosis. Methods We collected 82 cases of surgically resected NSCLC tissues and 69 cases of adjacent normal tissue(>5 cm away from cancer tissue)from January 2013 to December 2015. The expressions of miR-449a/b/c of above tissues were detected by using real-time fluorescence quantitative PCR (QPCR). The differences of distribution of miR-449a/b/c expressions in NSCLC and adjacent normal tissues were compared. Pearson correlation analysis of miR-449a,miR-449b and miR-449c in NSCLC tissues was undergone. The relationship of miR-449a/b/c expressions in NSCLC with clinical pathological parameters(gender,age,tumor size,TNM stage,histological type and lymph node metastasis)were analyzed. According to the follow-up data,the prognosis of different expressions of miR-449a/b/c was compared. Results QPCR results showed that in NSCLC tissues, the avarage expressions of miR-449a,miR-449b and miR-449c were 0.210±0.028,0.359±0.031 and 0.133±0.020,lower than those in adjacent normal tissues,and the differences were statistically significant (P<0.05). The expressions of miR449a,miR-449b and miR449c were positively correlated in NSCLC and correlation coefficients for miR-449a/b, miR-449a/c and miR-449b/c were 0.246,0.390 and 0.331 (P<0.05). The miR-449a/b/c levels of NSCLC tissues were significantly associated with TNM stage,and miR-449a and miR-449c were related to tumor size. All patients were followed up,and the median overall survival(OS)was 12.4 months. The median OS for miR-449a low expression group and high expression group were 11.2 and 13.5 months (P>0.05). The median OS for miR-449b low expression group and high expression group were 9.6 and 14.2 months (P<0.05). The median OS for miR-449c low expression group and high expression group were 11.7 and 13.7 months(P>0.05). Conclusion The expression of miR-449a/b/c in NSCLC tissues was decreased,and all of them were related to TNM stage. The expression of miR-449b was related to prognosis,which may be related to the occurrence and development of NSCLC. It has some value in the diagnosis and evaluation of NSCLC.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!